Cargando…
Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up
Background and Purpose. The main goal of the study was to assess the usefulness of plasma concentrations of catestatin as a predictor of a composite endpoint (CE): unplanned hospitalization and death for all causes in patients with HFrEF in the midterm follow-up. Experimental Approach. The study gro...
Autores principales: | Wołowiec, Łukasz, Rogowicz, Daniel, Banach, Joanna, Gilewski, Wojciech, Sinkiewicz, Władysław, Grześk, Grzegorz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556099/ https://www.ncbi.nlm.nih.gov/pubmed/33082887 http://dx.doi.org/10.1155/2020/8847211 |
Ejemplares similares
-
Prognostic Value of Plasma Catestatin Concentration in Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up
por: Wołowiec, Łukasz, et al.
Publicado: (2023) -
The Clinical Significance of Drug–Food Interactions of Direct Oral Anticoagulants
por: Grześk, Grzegorz, et al.
Publicado: (2021) -
Procalcitonin (PCT) Predicts Worse Outcome in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF)
por: Banach, J., et al.
Publicado: (2018) -
Alcohol and Cardiovascular Diseases—Do the Consumption Pattern and Dose Make the Difference?
por: Chudzińska, Małgorzata, et al.
Publicado: (2022) -
Implementation of recommendations on the check of risk factors for cardiovascular diseases in patients undergoing coronary re-interventions
por: Walukiewicz, Marcin, et al.
Publicado: (2023)